logo

ONCY

Oncolytics Biotech·NASDAQ
--
--(--)
--
--(--)
4.41 / 10
Netural

Capital flow data indicate a strong, positive trend with a 7.65/10 score. Ratios show consistent inflows across block, small, large, and extra-large categories, with the exception of a slightly negative Medium trend. This robust fund inflow aligns with the overwhelmingly bullish analyst consensus—100% Strong Buy from a single research source—and supports the stock despite its technical and fundamental challenges. The positive sentiment and capital support create a favorable backdrop for potential price appreciation if fundamentals improve.

FundamentalSentiment(4.41)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

100%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-11-17
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for ONCY?
  • ONCY holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 4.41/10 (Netural).